Bailard’s PharMerica Corporation PMC Stock Holding History

Bailard’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,000	Closed	-$420K	–	381
2015 Q4	$420K	Buy	+12,000	New	+$376K	0.18%	148

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCP

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bailard's PMC Position: Q1 2016 in Review

Bailard sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 12,000 shares — an estimated $420K sold.

Bailard first reported a position in PMC in Q4 2015 and held it in 1 quarter. The position peaked at $420K in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

Bailard reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
Bailard sold 12,000 PharMerica Corporation shares in Q1 2016, an estimated $420K.
Bailard first reported a position in PharMerica Corporation in Q4 2015 and held it in 1 quarter.
Bailard's PharMerica Corporation position peaked at $420K in Q4 2015.
169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Bailard's 13F filing for Q1 2016, filed 16 May 2016.